Search Results - "Eremkina, A K"

Dynamic changes of renin-angiotensin-aldosterone system parameters after surgery of primary hyperparathyroidism by Dobreva, E A, Bibik, E E, Eremkina, A K, Ajnetdinova, A R, Nikankina, L V, Malysheva, N M, Mokrysheva, N G

“…To study an activity of the Renin-Angiotensin-Aldosterone System (RAAS) components in patients with primary hyperparathyroidism (PHPT) before and after…”
Get full text

Recombinant human parathyroid hormone in the therapy of hypoparathyroidism by A K Eremkina, N G Mokrysheva, E V Kovaleva, Yu A Krupinova

“…Hypoparathyroidism is an endocrine disease that results from deficiency or complete absence of parathyroid hormone (PTH), a biologically active 84-amino acid…”
Get full text

Hypercalciuria and hyperparathyroidism — is there always a connection? by Mirnaya, S. S., Eremkina, A. K.

“…Hypercalciuria is a pathological condition characterized by an excess of daily calcium excretion. A high concentration of urine calcium can initiate stone…”
Get full text

Paricalcitol in management of chronic kidney disease–mineral and bone disorder by Eremkina, A. K., Mokrysheva, M. G.

“…Mineral and bone disorders in chronic kidney disease (CKD) is a systemic disorder of mineral and bone metabolism due to CKD manifested by either one or…”
Get full text

Association between preoperative cholecalciferol therapy and hypocalcemia after parathyroidectomy in patients with primary hyperparathyroidism by Elfimova, A. R., Eremkina, A. K., Rebrova, O. Yu, Kovaleva, E. V., Mokrysheva, N. G.

“…BACKGROUND : Primary hyperparathyroidism (PHPT) is a endocrine disorder characterized by excessive secretion of parathyroid hormone (PTH) from parathyroid…”
Get full text

Comparative analysis of bone complications/manifestations in sporadic and MEN1-related primary hyperparathyroidism by Pylina, S. V., Eremkina, A. K., Elfimova, A. R., Gorbacheva, A. M., Mokrysheva, N. G.

“…BACKGROUND : Multiple endocrine neoplasia type 1 (MEN1) — is a rare syndrome with an autosomal dominant inheritance pattern caused by a mutation in the tumor…”
Get full text

The daily calcium profile in patients with chronic hypoparathyroidism depending on different 25(OH) vitamin D level by Kovaleva, E. V., Eremkina, A. K., Elfimova, A. R., Gorbacheva, A. M., Mokrysheva, N. G.

“…BACKGROUND: Chronic hypoparathyroidism is a relatively rare disease, which usually treated active forms of vitamin D and oral calcium supplements…”
Get full text

Daily calcium profile in diagnosis of hypo- and hypercalcemia in patients with chronic hypoparathyroidism. clinical case series by Kovaleva, E. V., Eremkina, A. K., Mokrysheva, N. G.

“…Hypoparathyroidism is a rare endocrine disorder characterized by hypocalcemia and hyperphosphatemia, due to absent or inappropriately low serum parathyroid…”
Get full text

Bone disorders in type 1 multiple endocrine neoplasia syndrome: A review of clinical data by Gorbacheva, A. M., Eremkina, A. K., Mokrysheva, N. G.

“…Primary hyperparathyroidism (PHPT) is a result of the parathyroid tumors, usually manifesting by elevated serum parathyroid hormone and hypercalcemia. One of…”
Get full text

Soluble endoglin as a perspective marker of endothelial dysfunction in patients with primary hyperparathyroidism: a pilot study by Gorbacheva, A. M., Bibik, E. E., Dobreva, E. A., Elfimova, A. R., Eremkina, A. K., Mokrysheva, N. G.

“…BACKGROUND : Primary hyperparathyroidism  (PHPT), one of the most common endocrine pathologies, is associated with a higher incidence of cardiovascular…”
Get full text

Sporadic primary hyperparathyroidism with multiple parathyroid adenomas by Bibik, E. E., Eremkina, A. K., Knyazeva, O. A., Mokrysheva, N. G.

“…Multiple lesions of the parathyroid glands (PTG) in primary hyperparathyroidism (PHPT) can be sporadic or develop as part of hereditary syndromes, manifesting…”
Get full text

Changes of metabolic parameters in patients with primary hyperparathyroidism of different age groups by Bibik, E. E., Gorbacheva, A. M., Dobreva, E. A., Elfimova, A. R., Eremkina, A. K., Mokrysheva, N. G.

“…BACKGROUND: Studies have shown a high incidence of metabolic disorders and cardiovascular diseases in patients with primary hyperparathyroidism (PHPT). PHPT is…”
Get full text

Differential diagnosis of idiopathic hypoparathyroidism: a case series by Afonasyeva, T. M., Kovaleva, E. V., Eremkina, A. K., Mokrysheva, N. G.

“…Idiopathic hypoparathyroidism is a rare endocrine disease diagnosed when all possible causes of hypoparathyroidism are excluded.Data on the prevalence of…”
Get full text

Case of clinically “aggressive” course of primary hyperparathyroidism, algorithm of differential diagnosis by Matyushkina, A. S., Gorbacheva, A. M., Tkachuk, A. V., Eremkina, A. K., Mokrysheva, N. G.

“…Primary hyperparathyroidism (PHPT) is a significant endocrine disease caused by increased production of parathyroid hormone (PTH) by altered parathyroid glands…”
Get full text

Primary hyperparathyroidism in pregnancy after in vitro fertilization by Bondarenko, A. S., Bibik, E. E., Voskoboynikov, V. V., Kolegaeva, O. I., Sazonova, A. I., Eremkina, A. K., Lunyakina, O. V., Ionanidze, T. Yu, Aksenenko, A. A., Esayan, R. M., Tetruashvili, N. K., Platonova, N. M., Mokrysheva, N. G.

“…Primary hyperparathyroidism (PHPT) in pregnant women is a rare condition, often remaining undiagnosed due to non-specific clinical symptoms. However, it can…”
Get full text

Predicting the presence of MEN1 gene mutation based on the clinical phenotype of patients with primary hyperparathyroidism by Mokrysheva, N. G., Eremkina, A. K., Miliutina, A. P., Salimkhanov, R. Kh, Aboishava, L. A., Bibik, E. E., Gorbacheva, A. M., Elfimova, A. R., Kovaleva, E. V., Popov, S. V., Melnichenko, G. A.

“…BACKGROUND: Timely referral of patients for genetic testing to rule out MEN1-associated primary PHPT is important factor in determining treatment strategy and…”
Get full text

Dihydrotachysterol: a bad choice in the treatment of chronic hypoparathyroidism by Avsievich, E. S., Kovaleva, E. V., Gorbacheva, A. M., Eremkina, A. K., Mokrysheva, N. G.

“…Hypoparathyroidism is an endocrine disease caused by damage of the parathyroid glands and characterized by underproduction of parathyroid hormone. This can…”
Get full text

Dynamics the parameters of mineral metabolism in hospitalized patients with COVID-19, the impact of etiotropic and pathogenetic therapy by Maganeva, I. S., Bondarenko, A. S., Miliutina, A. P., Elfimova, A. R., Bibik, E. E., Nikankina, L. V., Tarbaeva, N. V., Eremkina, A. K., Mokrysheva, N. G.

“…The high prevalence of COVID-19 requires the research progress on the disease pathogenesis. There is a lot of data confirming the association between mineral…”
Get full text

Phosphopenic form of osteomalacia in a patient with FGF23 producing tumor by Pushkareva, A. S., Bibik, E. E., Eremkina, A. K., Degtyarev, M. V., Mokrysheva, N. G.

“…Oncogenic osteomalacia is an orphan disease caused by the overproduction of fibroblast growth factor 23 (FGF23) in tumors, which leads to impaired bone matrix…”
Get full text

The structure of mineral and bone disorders in patients with сhronic kidney disease of the 5th dialysis stage, taking into account the presence or absence of a diagnosis of type 1 diabetes mellitus by Maganeva, I. S., Eremkina, A. K., Miliutina, A. P., Martynov, S. A., Severina, A. S., Salimkhanov, R. H., Evloeva, M. I., Shamkhalova, M. Sh, Shestakova, M. V., Mokrysheva, N. G.

“…BACKGROUND: In patients with end-stage CKD, receiving renal replacement therapy (RRT) with programmed hemodialysis (HD), the severity of complications is…”
Get full text